儿童及年轻成人松果体母细胞瘤年龄依赖治疗策略评估:欧洲儿科肿瘤学会(SIOP-E)与美国Head Start数据汇总分析
该研究汇总国际前瞻性治疗与结局数据,分析135例0.01-20.7岁松果体母细胞瘤患者。年龄≥4岁和接受放疗为有利预后因素,转移性疾病为不利因素。年轻患儿未放疗者生存差,大龄非转移患者CSI联合化疗有效。
要点
- 年龄≥4岁与接受放疗为有利预后因素,转移性疾病为不利因素。
- 57例<4岁患者5年PFS/OS为11±4%/12±4%,未放疗者生存差。
- 78例≥4岁无转移患者PFS/OS为72±7%/73±7%,有转移者为50±10%/55±10%。
核心结论
- 年轻儿童未接受放疗者生存差;在缺乏更特异或靶向治疗的情况下,大剂量化疗联合局部放疗可能值得进一步评估。
- CSI联合化疗对年长非转移性患者有效。
研究设计与样本
- 汇总国际试验组的前瞻性治疗与结局数据,采用Cox回归模型将治疗因素作为时间依赖协变量。
- 共分析135例松果体母细胞瘤患者,年龄0.01-20.7岁(中位4.9岁),中位观察时间7.3年。
主要发现
- 有利预后因素为年龄≥4岁(无进展生存[PFS]的风险比[HR] 0.270,P<.001)和接受放疗(PFS的HR 0.282,P<.001)。
- 转移性疾病与不良预后相关(PFS的HR 2.015,P=.006),术后残留肿瘤则不然。
- 57例<4岁患者5年PFS/总生存(OS)为11±4%/12±4%;仅化疗后2例存活,16例接受颅脊髓照射(CSI)加推量者中3例存活,5例接受大剂量化疗(HDCT)加局部放疗者中3例存活。
- 78例≥4岁患者中,无转移者PFS/OS为72±7%/73±7%,有转移者为50±10%/55±10%。
- 73例接受放疗(48例常规分割CSI,中位剂量35.0[18.0-45.0]Gy;19例超分割CSI;6例局部放疗),其中68例联合化疗、6例未联合化疗;治疗顺序无影响,HDCT对年长患者生存影响微弱。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pineoblastoma is a rare pineal region brain tumor. Treatment strategies have reflected those for other malignant embryonal brain tumors. PATIENTS AND METHODS: Original prospective treatment and outcome data from international trial groups were pooled. Cox regression models were developed considering treatment elements as time-dependent covariates. RESULTS: Data on 135 patients with pineoblastoma aged 0.01-20.7 (median 4.9) years were analyzed. Median observation time was 7.3 years. Favorable prognostic factors were age ≥4 years (hazard ratio [HR] for progression-free survival [PFS] 0.270, P < .001) and administration of radiotherapy (HR for PFS 0.282, P < .001). Metastatic disease (HR for PFS 2.015, P = .006), but not postoperative residual tumor, was associated with unfavorable prognosis. In 57 patients <4 years old, 5-year PFS/overall survival (OS) were 11 ± 4%/12 ± 4%. Two patients survived after chemotherapy only, while 3 of 16 treated with craniospinal irradiation (CSI) with boost, and 3 of 5 treated with high-dose chemotherapy (HDCT) and local radiotherapy survived. In 78 patients aged ≥4 years, PFS/OS were 72 ± 7%/73 ± 7% for patients without metastases, and 50 ± 10%/55 ± 10% with metastases. Seventy-three patients received radiotherapy (48 conventionally fractionated CSI, median dose 35.0 [18.0-45.0] Gy, 19 hyperfractionated CSI, 6 local radiotherapy), with (n = 68) or without (n = 6) chemotherapy. The treatment sequence had no impact; application of HDCT had weak impact on survival in older patients. CONCLUSION: Survival is poor in young children treated without radiotherapy. In these patients, combination of HDCT and local radiotherapy may warrant further evaluation in the absence of more specific or targeted treatments. CSI combined with chemotherapy is effective for older non-metastatic patients.
引用
- Mynarek M, Pizer B, Dufour C, et al. Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro Oncol. 2017. PMID: 28011926. doi:10.1093/neuonc/now234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。